The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.
about
A very late viral protein triggers the lytic release of SV40Regulation of apoptosis by viral gene productsHepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.The adenovirus L4-22K protein has distinct functions in the posttranscriptional regulation of gene expression and encapsidation of the viral genome.The adenovirus L4-22K protein is multifunctional and is an integral component of crucial aspects of infection.Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coliHtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA)Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamstersA novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands.Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus.Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release.Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirusPre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelLinked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenovirusesControl of adenovirus early gene expression during the late phase of infection.The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis.Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vectorTumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death proteinInduction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A.Intracellular hepatitis B virus nucleocapsids survive cytotoxic T-lymphocyte-induced apoptosisTissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.Genetic identification of adenovirus type 5 genes that influence viral spread.No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection.Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal speciesHuman adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activityOncolytic adenoviruses: A thorny path to glioma cureMutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells.A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKsHerpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane.Analysis of early region 3 mutants of mouse adenovirus type 1A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents.New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.Cell Walls and the Convergent Evolution of the Viral Envelope.Identification of a new human adenovirus protein encoded by a novel late l-strand transcription unit.Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.
P2860
Q21559509-B65AA105-B709-49DA-9108-A5DEE37C4AD1Q24678703-2FAC2006-158A-480D-B1B5-8B47018F17F7Q27469538-B49BBAC2-7D24-42F2-9BF8-48E0639F4AD4Q30415541-914AB4B4-9E76-4E81-9A03-D24F4B528111Q30421658-C7078AEB-5005-4C17-85D8-90E3F07AF795Q30525107-6197175D-1273-4B63-9185-FB2B28BB27D9Q33252754-62E8B59C-51F4-4272-B631-6494CD3973F4Q33366478-5ABF273D-C6EE-487F-A5FF-ADC2BD8943D6Q33580223-D5687CB7-ABF9-483E-BE85-7A41712BC4C2Q33586270-460FC87E-26A9-4960-B11C-29329A93D494Q33622711-B607447E-FB0B-4D93-80BC-F478C5383546Q33646578-8A9E0F7E-2097-4A0B-8016-C41A386F113FQ33690982-E0D283C2-451F-4FD9-8632-BDF6F0DFC2DFQ33713048-17D2D763-2C22-4B35-8152-2F21847ED764Q33755007-F2A993DB-E4DE-40A7-9DED-9A6B27F0E4F8Q33782748-92B9D474-EB62-4FE8-8499-BD00C9952CEBQ33783779-D209C423-D40A-4CBC-AEB2-19E0559BD30AQ33799667-CFDEF97C-3B47-4E3A-86ED-702A7B9A8473Q33807026-8E3E438C-EB48-496B-A9EE-57C1FDFB139EQ33810466-15B48B4F-D453-434E-B15A-AE5EEC976AE7Q33812052-2600EEEC-1582-4781-9576-BE42C3CA7FCDQ33838380-7D65B39F-877C-4665-9679-40CCB94E3437Q33844897-2E3349F1-CFCD-4B2B-BB26-5309FB26434FQ34353556-41143AA7-964A-49A3-948F-6D9FAFE9960FQ34375562-F0595544-FD49-473E-9024-6449591D81AEQ34430268-1E9C5756-6617-4D70-AB78-2844A3219115Q34545667-8D771D56-DF8A-4734-8CBC-E0B79AAC9DD5Q35076737-CD6EFC1C-47D3-452C-A095-5B1E92444CF4Q35077747-14CC8003-CF68-4ABB-BA43-2579E50A9376Q35105144-62FC3FC9-AD52-4182-9402-FF384993FB0CQ35145614-6D8FE2D4-718A-439B-84C6-8B687BCB2A17Q35840414-73AB6503-C3E7-4F86-A7FA-06DB955BC49AQ35867799-39B593EE-D98D-4969-ADD1-67EC44222F11Q35874291-4BC3814B-0F19-40F2-AA88-A9A3BD74D045Q36209172-43CF93D1-D456-4944-AED8-2D9EB71DA6F3Q36209205-1FEF0E29-54E2-412A-84D3-12371F9FBF7BQ36221386-D0878A19-BB29-48C0-9696-0C0B4A8A698DQ36294722-494EF8FB-3B51-42F0-BCED-48851AE3295BQ36315832-9EC9C1D3-4BDA-4906-8FFA-8249F06FD24CQ36387903-A8C40445-4065-4F55-B091-7183F7D06546
P2860
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The adenovirus death protein ( ...... denovirus from infected cells.
@ast
The adenovirus death protein ( ...... denovirus from infected cells.
@en
type
label
The adenovirus death protein ( ...... denovirus from infected cells.
@ast
The adenovirus death protein ( ...... denovirus from infected cells.
@en
prefLabel
The adenovirus death protein ( ...... denovirus from infected cells.
@ast
The adenovirus death protein ( ...... denovirus from infected cells.
@en
P2093
P2860
P1433
P1476
The adenovirus death protein ( ...... denovirus from infected cells.
@en
P2093
A E Tollefson
J S Ryerse
T W Hermiston
P2860
P304
P407
P577
1996-04-01T00:00:00Z